TMC Life Sciences Berhad (KLSE:TMCLIFE)

Malaysia · Delayed Price · Currency is MYR

0.4200

+0.0050 (1.20%)

At close: Oct 30, 2026

Market Cap	731.59M -8.7%
Revenue (ttm)	393.03M +13.7%
Net Income	17.38M +382.0%
EPS	0.01 +382.0%
Shares Out	1.74B
PE Ratio	42.10
Forward PE	n/a
Dividend	0.01 (1.37%)
Ex-Dividend Date	Dec 8, 2026

Volume	67,000
Open	0.4150
Previous Close	0.4150
Day's Range	0.4150 - 0.4250
52-Week Range	0.4000 - 0.5750
Beta	0.33
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 17, 2026

About TMC Life Sciences Berhad

TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support services; development, marketing, and management of healthcare programmes; a... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified

Founded 1994

Country Malaysia

Stock Exchange Bursa Malaysia

Ticker Symbol TMCLIFE

Full Company Profile

Financial Performance

In fiscal year 2026, TMC Life Sciences Berhad's revenue was 393.03 million, an increase of 13.71% compared to the previous year's 345.63 million. Earnings were 17.38 million, an increase of 381.97%.

Financial Statements